As previously reported, Compass Point analyst Joe Flynn initiated coverage of Applied Digital (APLD) with a Buy rating and $10 price target The firm, which notes that its target offers 50% upside ...
As previously reported, Compass Point upgraded Affirm (AFRM) to Neutral from Sell with a price target of $61, up from $20. The firm’s previous valuation “underappreciated” Affirm’s ability ...
Fintel reports that on January 28, 2025, Compass Point downgraded their outlook for Synchrony Financial (LSE:0LC3) from Buy to Neutral. As of January 29, 2025, the average one-year price target ...
In a report released today, Dominick Gabriele from Compass Point reiterated a Hold rating on American Express (AXP – Research Report), with a price target of $309.00. The company’s shares ...
Investing.com -- Compass Point has initiated coverage of Curbline Properties Corp (NYSE:CURB) with a “neutral” rating and a price target of $24 given company’s unique focus on unanchored ...
Investing.com -- Compass Point has initiated coverage of Curbline Properties Corp (NYSE:CURB) with a “neutral” rating and a price target of $24 given company’s unique focus on unanchored convenience ...
Compass also caused jitters amongst its investors as it revealed that it will shift the data readout for phase 3 trials of the psilocybin-based COMP360 therapy until after the 26-week time point ...
A compass is a navigational instrument that identifies the cardinal points—North, East, South, and West, including intermediate directions. The most reliable and best compasses work by using the ...
The cardinal points of the Compass Strategy that will guide EU and influence national policies are: To achieve these objectives, the Compass Strategy outlines initiatives in two directions ...
Liverpool have 46 points at the half-way stage of their Premier League season, sitting six points ahead of Arsenal in the Premier League table with a game in hand. But how does that measure up ...
The supplier points to a smaller number of customers moving to Nutanix and Hyper-V. This suggests a larger percentage of VMware users have either decided to stay with the technology and the new ...
UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment based on psilocybin – an active ingredient that can be found in magic mushrooms.